Foghorn Therapeutics Inc.(FHTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FHTX Foghorn Therapeutics Inc.

交易中 03-04 10:36:06 EST

5.74

+0.22

+3.99%

最高5.79	最低5.44	成交量1.49万
今开5.59	昨收5.52	日振幅6.34%
总市值3.36亿	流通市值1.66亿	总股本5,858万
成交额8.44万	换手率0.05%	流通股本2,887万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"FHTX","market":"US","secType":"STK","nameCN":"Foghorn Therapeutics Inc.","latestPrice":5.74,"timestamp":1772638563886,"preClose":5.52,"halted":0,"volume":14938,"delay":0,"changeRate":0.03985507246376824,"floatShares":28868800,"shares":58581600,"eps":-1.146021,"marketStatus":"交易中","change":0.22,"latestTime":"03-04 10:36:06 EST","open":5.59,"high":5.79,"low":5.44,"amount":84351.55034460001,"amplitude":0.063406,"askPrice":5.81,"askSize":25,"bidPrice":5.63,"bidSize":4,"shortable":3,"etf":0,"ttmEps":-1.146021,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772658000000},"marketStatusCode":2,"adr":0,"listingDate":1603425600000,"exchange":"NASDAQ","adjPreClose":5.52,"postHourTrading":{"tag":"盘后","latestPrice":5.52,"preClose":5.52,"latestTime":"19:26 EST","volume":3883,"amount":21434.23,"timestamp":1772583962464,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.648176,"impliedVol":1.0975,"impliedVolPercentile":0.3705},"requestUrl":"/m/hq/s/FHTX","defaultTab":"news","newsList":[{"id":"1154855991","title":"Foghorn Therapeutics任命Ryan Maynard为首席财务官，强化财务领导团队","url":"https://stock-news.laohu8.com/highlight/detail?id=1154855991","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154855991?lang=zh_cn&edition=full","pubTime":"2026-02-23 20:02","pubTimestamp":1771848135,"startTime":"0","endTime":"0","summary":"Foghorn Therapeutics Inc. (FHTX) 宣布任命Ryan Maynard为公司新任首席财务官，此举旨在加强其财务管理团队的实力。Maynard将负责领导公司的财务战略规划、资本管理及投资者关系等核心事务，为公司的长期发展提供坚实的财务支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FHTX"],"gpt_icon":0},{"id":"2605284724","title":"Foghorn Therapeutics Inc.盘中异动 快速跳水5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605284724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605284724?lang=zh_cn&edition=full","pubTime":"2026-01-24 04:00","pubTimestamp":1769198414,"startTime":"0","endTime":"0","summary":"北京时间2026年01月24日04时00分，Foghorn Therapeutics Inc.股票出现异动，股价急速跳水5.16%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Coherus Oncology, Inc.、Collplant Biotechnologies Ltd.、Scinai Immunotherapeutics Ltd涨幅较大，Revelation Biosciences, Inc.、60 Degrees Pharmaceuticals, Inc.、Aditxt, Inc.较为活跃，换手率分别为1447.84%、165.05%、50.83%，振幅较大的相关个股有Revelation Biosciences, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为99.49%、60.41%、58.89%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124040014a44f739a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124040014a44f739a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FHTX","LENZ","BK4539","BK4007","BK4139"],"gpt_icon":0},{"id":"1167611957","title":"Foghorn Therapeutics完成5000万美元注册直接融资，发行价溢价30%","url":"https://stock-news.laohu8.com/highlight/detail?id=1167611957","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167611957?lang=zh_cn&edition=full","pubTime":"2026-01-14 05:06","pubTimestamp":1768338403,"startTime":"0","endTime":"0","summary":"临床阶段生物技术公司Foghorn Therapeutics Inc.今日宣布，已完成一笔5000万美元的注册直接融资，发行价较市场价溢价30%。此次发行以每股6.71美元的价格售出2,030,314股普通股。所有股份均由Foghorn出售，融资总收益约为5000万美元。Foghorn Therapeutics致力于发现和开发一类新型药物，靶向染色质调控系统中由基因决定的依赖性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4139","R","BK4022","FHTX"],"gpt_icon":0},{"id":"1146675657","title":"Foghorn Therapeutics 第三季度每股收益为 -0.25 美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1146675657","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146675657?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:42","pubTimestamp":1763570551,"startTime":"0","endTime":"0","summary":"11月5日 - Foghorn Therapeutics 第三季度的合作收入为 815.3 万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHTX","BK4139"],"gpt_icon":0},{"id":"2583631770","title":"Foghorn Therapeutics Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583631770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583631770?lang=zh_cn&edition=full","pubTime":"2025-11-15 00:39","pubTimestamp":1763138374,"startTime":"0","endTime":"0","summary":"北京时间2025年11月15日00时39分，Foghorn Therapeutics Inc.股票出现异动，股价急速拉升5.05%。截至发稿，该股报4.58美元/股，成交量2.9684万股，换手率0.05%，振幅7.57%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.31%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115003935a4a20ce6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251115003935a4a20ce6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4539","BK4139","FHTX"],"gpt_icon":0},{"id":"1105278157","title":"Foghorn Therapeutics Inc. - Kristian Humer于10月31日辞去CFO职务，生效日期为2025年11月14日 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1105278157","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105278157?lang=zh_cn&edition=full","pubTime":"2025-11-05 20:11","pubTimestamp":1762344684,"startTime":"0","endTime":"0","summary":"Foghorn Therapeutics Inc. - Kristian Humer于10月31日辞去CFO职务，生效日期为2025年11月14日 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHTX","BK4139"],"gpt_icon":0},{"id":"1122526870","title":"Foghorn Therapeutics公布选择性Arid1b、选择性Cbp和选择性Ep300降解剂项目的最新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1122526870","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122526870?lang=zh_cn&edition=full","pubTime":"2025-10-30 19:31","pubTimestamp":1761823877,"startTime":"0","endTime":"0","summary":"Foghorn Therapeutics公布选择性Arid1b、选择性Cbp和选择性Ep300降解剂项目的最新进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FHTX"],"gpt_icon":0},{"id":"2578506487","title":"Foghorn Therapeutics Inc.盘中异动 下午盘大幅上涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578506487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578506487?lang=zh_cn&edition=full","pubTime":"2025-10-25 02:58","pubTimestamp":1761332298,"startTime":"0","endTime":"0","summary":"北京时间2025年10月25日02时58分，Foghorn Therapeutics Inc.股票出现异动，股价大幅上涨5.13%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Inhibrx Biosciences, Inc.、Genenta Science Spa、Theriva Biologics, Inc.涨幅较大，Neuphoria Therapeutics Inc.、Theriva Biologics, Inc.、Qualigen Therapeutics, Inc.较为活跃，换手率分别为3431.16%、2773.06%、2471.01%，振幅较大的相关个股有Theriva Biologics, Inc.、Genenta Science Spa、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为134.04%、133.75%、84.64%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251025025819a6cc873c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251025025819a6cc873c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FHTX","LENZ","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"1116612316","title":"Foghorn Therapeutics在第八届TPD及诱导接近峰会上宣布选择性Arid1b降解剂的重要进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1116612316","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116612316?lang=zh_cn&edition=full","pubTime":"2025-10-16 19:01","pubTimestamp":1760612477,"startTime":"0","endTime":"0","summary":"Foghorn Therapeutics在第八届TPD及诱导接近峰会上宣布选择性Arid1b降解剂的重要进展","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FHTX"],"gpt_icon":0},{"id":"2573967648","title":"Foghorn Therapeutics Inc.盘中异动 早盘股价大涨6.84%报4.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2573967648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573967648?lang=zh_cn&edition=full","pubTime":"2025-10-07 21:45","pubTimestamp":1759844712,"startTime":"0","endTime":"0","summary":"北京时间2025年10月07日21时45分，Foghorn Therapeutics Inc.股票出现波动，股价急速拉升6.84%。截至发稿，该股报4.84美元/股，成交量3875股，换手率0.01%，振幅2.43%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510072145129722a5b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510072145129722a5b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FHTX","BK4007","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2568297232","title":"Foghorn Therapeutics Inc.盘中异动 大幅跳水6.42%报4.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568297232","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568297232?lang=zh_cn&edition=full","pubTime":"2025-09-19 23:40","pubTimestamp":1758296417,"startTime":"0","endTime":"0","summary":"北京时间2025年09月19日23时40分，Foghorn Therapeutics Inc.股票出现异动，股价大幅跳水6.42%。截至发稿，该股报4.81美元/股，成交量5.1221万股，换手率0.09%，振幅4.67%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919234017979d7619&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919234017979d7619&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","FHTX","BK4007"],"gpt_icon":0},{"id":"2518126227","title":"Foghorn Therapeutics Inc.盘中异动 早盘股价大跌6.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518126227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518126227?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:36","pubTimestamp":1741613793,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时36分，Foghorn Therapeutics Inc.股票出现波动，股价大幅下挫6.63%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为447.98%、67.42%、50.45%，振幅较大的相关个股有Akero Therapeutics, Inc.、Seer, Inc.、珐博进，振幅分别为100.05%、98.72%、98.49%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213633a26a26ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213633a26a26ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FHTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2517147501","title":"Foghorn Therapeutics(FHTX.US)：2024年Q4财报实现营收285.6万美元，前值为576.9万美元，预期值为814万美元；每股收益为-0.23美元，前值为-0.57美元，预期值为-0.27美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517147501","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517147501?lang=zh_cn&edition=full","pubTime":"2025-03-07 07:03","pubTimestamp":1741302184,"startTime":"0","endTime":"0","summary":"Foghorn Therapeutics(FHTX.US)：2024年Q4财报实现营收285.6万美元，前值为576.9万美元，预期值为814万美元；每股收益为-0.23美元，前值为-0.57美元，预期值为-0.27美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/07070348578858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","FHTX"],"gpt_icon":0},{"id":"1161545004","title":"Foghorn Therapeutics 2024财年GAAP每股收益$(1.58)优于$(1.61)预期，销售额$2260.2万低于$3071.3万预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1161545004","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161545004?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:18","pubTimestamp":1741295920,"startTime":"0","endTime":"0","summary":"Foghorn Therapeutics 报告季度每股亏损$，优于分析师预期的$，超出1.86%。公司报告季度销售额为$2260.2万，低于分析师预期的$3071.3万，低于预期26.41%。相比去年同期的$3415.5万，减少了33.83%。以上内容来自Benzinga Earnings专栏，原文如下：Foghorn $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 1.86 percent. This is a 32.48 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $22.602 million which missed the analyst consensus estimate of $30.713 million by 26.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","FHTX"],"gpt_icon":0},{"id":"2517592359","title":"Foghorn Therapeutics Inc.盘中异动 急速上涨6.29%报4.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517592359","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517592359?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:59","pubTimestamp":1741201172,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日02时59分，Foghorn Therapeutics Inc.股票出现波动，股价快速上涨6.29%。截至发稿，该股报4.67美元/股，成交量2.7506万股，换手率0.05%，振幅6.43%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.70%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306025933a26111d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306025933a26111d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FHTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2516634467","title":"Foghorn Therapeutics Inc.盘中异动 早盘急速下挫6.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634467?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:37","pubTimestamp":1741012643,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时37分，Foghorn Therapeutics Inc.股票出现波动，股价急速下挫6.19%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为48.51%、32.99%、31.59%，振幅较大的相关个股有Entero Therapeutics Inc.、Pliant Therapeutics, Inc.、Spruce Biosciences, Inc.，振幅分别为21.22%、19.85%、19.25%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032237249637add9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032237249637add9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","FHTX"],"gpt_icon":0},{"id":"2516372537","title":"Foghorn Therapeutics Inc.盘中异动 急速拉升5.18%报4.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516372537","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516372537?lang=zh_cn&edition=full","pubTime":"2025-03-01 01:09","pubTimestamp":1740762550,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日01时09分，Foghorn Therapeutics Inc.股票出现波动，股价急速拉升5.18%。截至发稿，该股报4.87美元/股，成交量2.5705万股，换手率0.05%，振幅5.62%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301010911a25827fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301010911a25827fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","FHTX"],"gpt_icon":0},{"id":"2514380125","title":"Foghorn Therapeutics Inc.盘中异动 快速下挫5.19%报4.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514380125","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514380125?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:53","pubTimestamp":1740675183,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时53分，Foghorn Therapeutics Inc.股票出现异动，股价快速下跌5.19%。截至发稿，该股报4.75美元/股，成交量4.439万股，换手率0.08%，振幅7.58%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228005303a2569c31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228005303a2569c31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FHTX","LENZ"],"gpt_icon":0},{"id":"2513291109","title":"Foghorn Therapeutics Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513291109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513291109?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:09","pubTimestamp":1740150579,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时09分，Foghorn Therapeutics Inc.股票出现异动，股价大幅下挫5.02%。截至发稿，该股报5.11美元/股，成交量4.9109万股，换手率0.09%，振幅7.62%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230939962b8476&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230939962b8476&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FHTX","LENZ"],"gpt_icon":0},{"id":"2512169426","title":"Foghorn Therapeutics Inc.盘中异动 早盘急速拉升5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512169426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512169426?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889118,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分，Foghorn Therapeutics Inc.股票出现波动，股价快速拉升5.87%。Foghorn Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为275.68%、90.87%、59.60%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Allakos Inc.、Virpax Pharmaceuticals, Inc.，振幅分别为8.57%、6.84%、6.13%。Foghorn Therapeutics Inc.公司简介：Foghorn Therapeutics Inc 致力于发现和开发一类新的药物，这些药物针对染色质调节系统中基因决定的依赖性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223158a24aaca8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223158a24aaca8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FHTX","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.foghorntx.com","stockEarnings":[{"period":"1week","weight":-0.0265},{"period":"1month","weight":-0.0333},{"period":"3month","weight":0.2432},{"period":"6month","weight":0.0241},{"period":"1year","weight":0.2778},{"period":"ytd","weight":0.0222}],"compareEarnings":[{"period":"1week","weight":-0.0102},{"period":"1month","weight":-0.0168},{"period":"3month","weight":-0.0052},{"period":"6month","weight":0.0481},{"period":"1year","weight":0.1654},{"period":"ytd","weight":-0.0023}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Foghorn Therapeutics Inc.成立于2015年10月。该公司率先发现并开发了一类针对染色质调节系统内基因决定依赖性的药物，这是一个尚未开发的治疗机会干预。该公司专有的基因流量控制平台为其提供了一个对染色质调节系统的各个组成部分如何相互作用的综合性、机械性理解，使其能够识别、验证系统内的潜在药物靶点。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.121231},{"month":2,"riseRate":0.333333,"avgChangeRate":0.145296},{"month":3,"riseRate":0.333333,"avgChangeRate":0.010003},{"month":4,"riseRate":0.4,"avgChangeRate":-0.077983},{"month":5,"riseRate":0.4,"avgChangeRate":0.013007},{"month":6,"riseRate":0.8,"avgChangeRate":0.067343},{"month":7,"riseRate":0.8,"avgChangeRate":0.112962},{"month":8,"riseRate":0.4,"avgChangeRate":0.016047},{"month":9,"riseRate":0.4,"avgChangeRate":-0.062466},{"month":10,"riseRate":0.2,"avgChangeRate":-0.136011},{"month":11,"riseRate":0.666667,"avgChangeRate":0.057074},{"month":12,"riseRate":0.666667,"avgChangeRate":0.19509}],"exchange":"NASDAQ","name":"Foghorn Therapeutics Inc.","nameEN":"Foghorn Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Foghorn Therapeutics Inc.(FHTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Foghorn Therapeutics Inc.(FHTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Foghorn Therapeutics Inc.,FHTX,Foghorn Therapeutics Inc.股票,Foghorn Therapeutics Inc.股票老虎,Foghorn Therapeutics Inc.股票老虎国际,Foghorn Therapeutics Inc.行情,Foghorn Therapeutics Inc.股票行情,Foghorn Therapeutics Inc.股价,Foghorn Therapeutics Inc.股市,Foghorn Therapeutics Inc.股票价格,Foghorn Therapeutics Inc.股票交易,Foghorn Therapeutics Inc.股票购买,Foghorn Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Foghorn Therapeutics Inc.(FHTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Foghorn Therapeutics Inc.(FHTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}